{"id":848,"date":"2024-06-13T13:33:34","date_gmt":"2024-06-13T13:33:34","guid":{"rendered":"https:\/\/www.merckvaccines.com\/rotateq\/?page_id=848"},"modified":"2026-03-02T20:19:50","modified_gmt":"2026-03-02T20:19:50","slug":"rotavirus-strain-coverage","status":"publish","type":"page","link":"https:\/\/www.merckvaccines.com\/rotateq\/rotavirus-strain-coverage\/","title":{"rendered":"Rotavirus Strain Coverage"},"content":{"rendered":"\n\n
<\/div>\"\"<\/picture>

Is your rotavirus vaccine indicated to help prevent RGE caused by G2?<\/strong>1<\/sup><\/mark><\/h1>

<\/p>

<\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div>\n\n\n\n\n
<\/div>\n\n\n\n\n

RotaTeq is the only rotavirus vaccine indicated to help protect against RGE caused by 5 strains, including G2<\/strong>1<\/sup><\/h2><\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n\n
\"\"\"\"<\/figure><\/div>\n\n\n\n
<\/div>\n\n\n\n

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age.<\/p>\n\n\n\n

<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\"\"\"\"<\/figure><\/div>\n\n\n\n
<\/div>\n\n\n\n

Rotarix<\/em> is indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series. Rotarix<\/em> is approved for use in infants 6 weeks and up to 24 weeks of age.1<\/sup><\/p>\n<\/div>\n<\/div>\n\n\n\n

G2 type – genetically distinct from other common rotavirus types.<\/strong>2,3<\/sup><\/h2><\/div>\n\n\n\n

These 5 common rotavirus strains belong to 2 distinct, minimally related genogroups.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n

Wa GENOGROUP<\/strong><\/p>\n\n\n\n

G1P[8]<\/strong><\/mark> , G3P[8]<\/strong><\/mark> ,G4P[8]<\/strong><\/mark>, G9[8]<\/strong><\/mark><\/p>\n<\/div>\n\n\n\n